Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simulations Plus (SLP)
NASDAQ:SLP
Holding SLP?
Track your performance easily
SLP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$27.07 - $51.22
Previous Close$31.77
Volume61.79K
Average Volume (3M)196.00K
Market Cap
$637.53M
Enterprise Value$618.29M
Total Cash (Recent Filing)$20.25M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)64.8
Beta1.30
Next Earnings
Jan 08, 2025EPS Estimate
$0.14Last Dividend Ex-Date
Jul 29, 2024Dividend Yield0.76%
Share Statistics
EPS (TTM)0.49
Shares Outstanding20,067,184
10 Day Avg. Volume165,669
30 Day Avg. Volume196,001
Standard Deviation0.14
R-Squared0.07
Alpha-0.00329
Financial Highlights & Ratios
Price to Book (P/B)3.03
Price to Sales (P/S)7.92
Price to Cash Flow (P/CF)83.30
P/FCF Ratio142.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.83
Enterprise Value/Gross Profit14.33
Enterprise Value/Ebitda37.36
Forecast
1Y Price Target
$52.50Price Target Upside65.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Simulations Plus News
PremiumCompany Announcements
Simulations Plus Reports 18% Revenue Increase for 2024
Bulls Say, Bears Say
Bulls Say
Business ModelSLP is a high quality business that addresses a core problem in life sciences clinical research—high costs to develop drugs with low probability of success—and has a demonstrated ROI by using computer models.
Financial PerformanceSLP provided its initial FY25 revenue outlook of $90M-$93M, representing a 29% increase at the midpoint.
Revenue GrowthSLP has a track record of success—a ~12% organic revenue growth CAGR over the last five years—by layering on additional modeling techniques or new intellectual property.
Bears Say
BacklogSLP ended the period with a $14.1M backlog, a decrease from $19.6M previously, due to bookings slippage and backlog cleanup.
EBITDAAdjusted EBITDA of $4.1M fell short of the analyst's estimate of $4.9M and the consensus of $4.3M.
RevenueSLP reported revenue of $18.7M, which was below both the analyst's estimate and consensus of $19.7M.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SLP FAQ
What was Simulations Plus’s price range in the past 12 months?
Simulations Plus lowest stock price was $27.07 and its highest was $51.22 in the past 12 months.
What is Simulations Plus’s market cap?
Currently, no data Available
When is Simulations Plus’s upcoming earnings report date?
Simulations Plus’s upcoming earnings report date is Jan 08, 2025 which is in 18 days.
How were Simulations Plus’s earnings last quarter?
Simulations Plus released its earnings results on Oct 23, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.049 by $0.011.
Is Simulations Plus overvalued?
According to Wall Street analysts Simulations Plus’s price is currently Undervalued.
Does Simulations Plus pay dividends?
Simulations Plus pays a Quarterly dividend of $0.059 which represents an annual dividend yield of 0.76%. See more information on Simulations Plus dividends here
What is Simulations Plus’s EPS estimate?
Simulations Plus’s EPS estimate is $0.14.
How many shares outstanding does Simulations Plus have?
Simulations Plus has 20,067,184 shares outstanding.
What happened to Simulations Plus’s price movement after its last earnings report?
Simulations Plus reported an EPS of $0.06 in its last earnings report, beating expectations of $0.049. Following the earnings report the stock price went down -8.888%.
Which hedge fund is a major shareholder of Simulations Plus?
Among the largest hedge funds holding Simulations Plus’s share is Royce & Associates LLC. It holds Simulations Plus’s shares valued at 8M.
---
Simulations Plus Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.50 (65.25% Upside)
$52.50 (65.25% Upside)
Blogger Sentiment
Bullish
SLP Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 50.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 13.2%
Last 30 Days ▼ 13.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.64%
12-Months-Change
Fundamentals
Return on Equity
5.65%
Trailing 12-Months
Asset Growth
7.78%
Trailing 12-Months
Company Description
Simulations Plus
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.
---
SLP Company Deck
---
SLP Earnings Call
Q4 2024
0:00 / 0:00
---
SLP Stock 12 Month Forecast
Average Price Target
$52.50
▲(65.25% Upside)
Technical Analysis
Best Analysts Covering SLP
1 Year
1 Year Success Rate
8/20 ratings generated profit
1 Year Average Return
-1.71%
reiterated a buy rating 2 months ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -1.71% per trade.
---